The role of combined oral contraceptives in the management of acne and seborrhea.
del Marmol
V
V
Dermatology Department, Erasmus Hospital, Université Libre de Bruxelles, Belgium.
Teichmann
A
A
Gertsen
K
K
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000503:physiopathology; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000503:physiopathology; D017135:Desogestrel / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009644:Norgestrel / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009652:Norpregnenes / Q000627:therapeutic use; D012449:Safety; D016896:Treatment Outcome
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D009652:Norpregnenes; C033273:Gestodene; D009644:Norgestrel; D004997:Ethinyl Estradiol; D017135:Desogestrel; C017576:norgestimate